Partner with us
News
Newel
Newel · September 16, 2025

Bridging the Gap: Why Newel Health is on the Ground with the NHS in London

Compliance & SecurityNewel ApproachUser Centered Approach
Newel
Newel · September 15, 2025

The Regulatory Paradox: Can Digital Therapeutics Be Safe and Engaging?

News
Newel
Newel · September 10, 2025

Redefining the Future of Care: Newel Health Partners with Frontiers Health Italy 2025

Behavioral Science & EmpathyNewel Approach
Dr. Silja-Riin Voolma
Dr. Silja-Riin Voolma · September 2, 2025

Why Engagement is the New Efficacy in Digital Health

News
Newel
Newel · June 11, 2025

A New Era for Hypertension Management: Amicomed Achieves EU MDR Certification

Compliance & SecurityNews
Newel
Newel · February 5, 2025

ROHKEA® VR Therapy Achieves MDR Class IIa Certification, Marking Major Milestone in Digital Therapeutics for Chronic Pain

NewsReal World Evidence
Newel
Newel · October 15, 2024

Newel Health Announces the Last Patient Last Visit (LPLV) in NWL-SOT-CS-001 Parkinson’s Disease Study Funded by The Michael J. Fox Foundation

News
Newel
Newel · April 24, 2024

Newel Health Appoints Ervin Ukaj as new CEO

News
Newel
Newel · January 29, 2024

Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain

General KnowledgeNews
Newel
Newel · January 15, 2024

Newel Health, Celebrating a year of Milestones and Achievements

Behavioral Science & EmpathyClinical ValidationDesign & UsabilityNewel Approach
Dr. Silja-Riin Voolma
Dr. Silja-Riin Voolma · January 4, 2024

Your science is rigorous. Is your design?

News
Newel
Newel · December 14, 2023

Newel Health Launches Groundbreaking Parkinson’s Disease Study Leveraging Real-World Data for Enhanced Treatment Strategies